Lir Life SciencesBBCMF 15 14-Day RSI is 38.76 as of Jun. 30, 2026. GuruFocus rates BBCMF with a GF Score™ of 15/100. Among 1,422 Biotechnology companies, Lir Life Sciences ranks better than 59.99% on this metric.
The Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. The RSI is most typically used on a 14-day period, measured on a scale from 0 to 100. Traditionally, an asset is considered overbought or overvalued when the RSI is above 70 and oversold or undervalued when it is below 30.
The industry rank for Lir Life Sciences's 14-Day RSI or its related term are showing as below:
BBCMF's 14-Day RSI is ranked better than 59.99% of 1422
companies
in the Biotechnology industry
Industry Median: 46
vs BBCMF: 38.76
Lir Life Sciences (OTCPK:BBCMF) 14-Day RSI Explanation
The Relative Strength Index (RSI), developed by J. Welles Wilder in his book “New Concepts in Technical Trading Systems.”, is a momentum oscillator that measures the speed and change of price movements. The RSI is most typically used on a 14-day period, measured on a scale from 0 to 100.
Traditionally, an asset is considered overbought or overvalued when the RSI is above 70 and oversold or undervalued when it is below 30. A RSI surpasses the 30 level indicates a bullish sign, when it slides below 70 level, it’s a bearish sign. This level can be adjusted depending on the security’s pattern and the market’s underlying trend. In an uptrend or bullish market, the RSI might range within a higher interval, investors could set the support level higher. If a downtrend or bearish market occurs, investors may need to lower the resistance level.
RSI can also be used in trading techniques to indicate the trading signal, such as Divergences and Swing Rejections.
Lir Life Sciences 14-Day RSI Related Terms
BBCMF vs VRTX, REGN, ALNY: 14-Day RSI Comparison
For the Biotechnology subindustry, Lir Life Sciences's 14-Day RSI, along with its competitors' market caps and 14-Day RSI data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Lir Life Sciences 14-Day RSI vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Lir Life Sciences's 14-Day RSI distribution charts can be found below:
* The bar in red indicates where Lir Life Sciences's 14-Day RSI falls into.
Lir Life Sciences (OTCPK:BBCMF) 14-Day RSI Calculation
The formula for calculating RSI is:
RSI
=
100
–
[ 100
/
( 1 + Average Gain
/
Average Loss )]
* Note that the formula uses a positive value for the average loss.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Lir Life Sciences (BBCMF) has a 14-Day RSI of 38.76 as of Jun. 30, 2026. Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. View historical data on Lir Life Sciences and its competitors. According to the industry distribution chart, Lir Life Sciences ranks #569 out of 1422 companies in the Biotechnology industry, placing it in the top 40%.
Is Lir Life Sciences' 14-Day RSI too high?
Lir Life Sciences' current 14-Day RSI is 38.76. The Biotechnology industry median 14-Day RSI is 46.00. Lir Life Sciences' value of 38.76 is 15.7% below this industry median. Based on the distribution chart, Lir Life Sciences ranks #569 out of 1422 companies in the Biotechnology industry, which is above the industry midpoint. Overall, Lir Life Sciences has a GF Score™ of 15/100, reflecting its overall financial health beyond just this single metric.
How does Lir Life Sciences' 14-Day RSI compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Lir Life Sciences ranks #569 out of 1422 companies for 14-Day RSI. This puts Lir Life Sciences in the upper half of its industry. The industry median 14-Day RSI is 46.00. Lir Life Sciences' value of 38.76 is 15.7% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 14-Day RSI for a Biotechnology company?
The median 14-Day RSI among Biotechnology companies is 46.00, based on 1,422 companies in the industry. Companies in the top quartile (top 25%) have a 14-Day RSI significantly above this median, while those in the bottom quartile fall well below. However, 14-Day RSI should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Lir Life Sciences's current 14-Day RSI of 38.76 is 15.7% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 14-Day RSI mean?
A high 14-Day RSI can signal that a stock is expensive relative to its fundamentals. Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. View historical data on Lir Life Sciences and its competitors. For the Biotechnology industry, the median 14-Day RSI is 46.00 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Lir Life Sciences's current 14-Day RSI is 38.76. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Lir Life Sciences stock overvalued right now?
Lir Life Sciences (BBCMF) has a current 14-Day RSI of 38.76. The current 14-Day RSI is 38.76 and 15.7% below the Biotechnology industry median of 46.00. Lir Life Sciences' overall GF Score™ is 15/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 14-Day RSI calculated?
14-Day RSI is calculated from a company's financial statements. For Lir Life Sciences (BBCMF), the current 14-Day RSI is 38.76 as of Jun. 30, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Address505-1505 West 2nd Avenue, Vancouver, BC, CAN, V6J 1H2
Lir Life Sciences Corp is a biotechnology company developing transdermal and sublingual drug-delivery technologies for GLP-1-based obesity therapies, with the focus of improving accessibility and patient experience.
15GF Score
Get the complete analysis for BBCMF
14-Day RSI is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BBCMF has been successfully added to your 